Swine flu recedes in North America, Europe, WHO says | Booster Shots | Los Angeles Times

ISSN-1554-7949: News links about and related to Europe - updated daily "The health of a democratic society may be measured by the quality of functions performed by its private citizens" - Alexis de Tocqueville

Concern in Germany as safety of swine flu vaccines questioned - by Derek Scally
Germany's swine flu vaccination program has been hit by public health concerns over the vaccines being used – one of which has been ordered by the Irish Government. Germany’s 16 federal states have spent a reported €600 million buying 50 million doses of the Pandemrix vaccine, produced by GlaxoSmithKline (GSK). This new vaccine, one of two to be offered by Irish doctors, is the subject of controversy in Germany because it contains a “booster” substance known as an “adjuvant”. This allows less virus material to be used per dose and, according to GSK, boosts the immune system’s response to the jab.
HEALTH ALERT: WHO Debates Whether To Declare Flu Pandemic
The World Health Organization (WHO) is consulting with its emergency committee of flu experts as the UN agency debates whether to declare a swine flu pandemic. A decision to declare a pandemic could trigger large-scale production of vaccines as the flu continues spreading worldwide. The June 11 meeting of the emergency committee of flu experts will help determine if that is the case. It comes just a day after reports from 74 countries to WHO indicated that the total number of confirmed flu infections worldwide has reached 27,737. The infections have resulted in 141 deaths. If the WHO does declare a pandemic, that would be a signal to health officials worldwide to plan for the possibility of larger numbers of people catching the virus. And the declaration could prompt pharmaceutical companies to speed up the production of vaccines in an effort to counter the flu’s spread. The disease, which was first detected in Mexico in March, is considered particularly threatening to younger adults.
Swine Flu: What You Need to Know - by Huma Khan
The rapidly spreading swine flu is a new virus that includes combination of swine, bird and human strains. It has taken the lives of 81 people in Mexico, and sickened more than a thousand south of the border. In the United States, 20 cases have been confirmed thus far -- seven in California, two in Kansas, eight in New York City, one in Ohio and two in Texas. Spain's Health Ministry Sunday said three persons have been brought to Spanish hospitals in the last 24 hours with symptoms of potential swine flu, in what may be the first recorded cases of the virus in Europe. Some other cases have also been detected in Canada, and Britain and France.
Simple preventive measures, such as washing hands frequently and avoiding people who are coughing or sneezing, can go a long way toward keeping you safe from the virus, which health officials expect is likely to afflict more people.
Concerns of the uncertainty and spread of the virus dealt a blow to the travel and leisure industry in Europe Monday. British Airways shares lost 11.5% and EasyJet fell 5.7% amid swine flu fears. TUI Travel declined 7.5% and Thomas Cook shed 4.8%. However, pharmaceutical and healthcare stocks got a boost. Shares of Switzerland's Roche rose 4.6%. The company said it stands ready to deliver 3 million doses of flu treatment Tamiflu, which has proven effective in treating swine flu. The U.K.'s GlaxoSmithKline rose 3.1%. The company has also been contacted by the WHO regarding its Relenza treatment, another antiviral drug.
Over the weekend, the World Health Organization declared the strain of swine flu to be a "public health emergency of international concern," with at least 103 people in Mexico dead, and advised all countries to be on the lookout for unusual outbreaks of flu.